Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramona J Petrovan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Biochemistry|July 24, 2002
Role of zymogenicity-determining residues of coagulation factor VII/VIIa in cofactor interaction and macromolecular substrate recognitionRamona J Petrovan, Wolfram Ruf
Journal of Lipid Research|November 6, 2007
Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient miceRamona J Petrovan, Yuan Yuan, Linda K Curtiss
Journal of Endotoxin Research|October 28, 2003
Activated protein C signals through the thrombin receptor PAR1 in endothelial cellsMatthias Riewald, Ramona J Petrovan, Aaron Donner, et al.
Proteins|October 28, 2003
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesisBrian V Norledge, Ramona J Petrovan, Wolfram Ruf, et al.
Thrombosis and Haemostasis|October 7, 2004
Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammationEllinor I B Peerschke, Ramona J Petrovan, Berhane Ghebrehiwet, et al.
Science (New York, N.Y.)|June 8, 2002
Activation of endothelial cell protease activated receptor 1 by the protein C pathwayMatthias Riewald, Ramona J Petrovan, Aaron Donner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient miceRamona J Petrovan, Charles D Kaplan, Ralph A Reisfeld, et al.
Cancer Research|September 23, 2003
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicryWolfram Ruf, Elisabeth A Seftor, Ramona J Petrovan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulinCatherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Biochemistry|July 24, 2002
Role of zymogenicity-determining residues of coagulation factor VII/VIIa in cofactor interaction and macromolecular substrate recognitionRamona J Petrovan, Wolfram Ruf
Journal of Lipid Research|November 6, 2007
Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient miceRamona J Petrovan, Yuan Yuan, Linda K Curtiss
Journal of Endotoxin Research|October 28, 2003
Activated protein C signals through the thrombin receptor PAR1 in endothelial cellsMatthias Riewald, Ramona J Petrovan, Aaron Donner, et al.
Proteins|October 28, 2003
The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesisBrian V Norledge, Ramona J Petrovan, Wolfram Ruf, et al.
Thrombosis and Haemostasis|October 7, 2004
Tissue factor pathway inhibitor-2 (TFPI-2) recognizes the complement and kininogen binding protein gC1qR/p33 (gC1qR): implications for vascular inflammationEllinor I B Peerschke, Ramona J Petrovan, Berhane Ghebrehiwet, et al.
Science (New York, N.Y.)|June 8, 2002
Activation of endothelial cell protease activated receptor 1 by the protein C pathwayMatthias Riewald, Ramona J Petrovan, Aaron Donner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 17, 2007
DNA vaccination against VEGF receptor 2 reduces atherosclerosis in LDL receptor-deficient miceRamona J Petrovan, Charles D Kaplan, Ralph A Reisfeld, et al.
Cancer Research|September 23, 2003
Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicryWolfram Ruf, Elisabeth A Seftor, Ramona J Petrovan, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2014
Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulinCatherine B Beidler, Ramona J Petrovan, Elaine M Conner, et al.
Pageof 1